Exosomes and solid cancer therapy: where are we now?

Area of Science:

• Oncology
• Immunology
• Biotechnology

Background:

• Cancer immunotherapy has transformed oncology, but solid tumors present challenges due to immune evasion and resistance.
• Exosomes, a type of extracellular vesicle, play a key role in intercellular communication and immune modulation within the tumor microenvironment.

Purpose of the Study:

• To review the multifaceted role of exosomes in solid cancer therapy.
• To discuss the mechanisms of action of exosomes in the tumor microenvironment.
• To highlight emerging strategies for overcoming clinical and technical hurdles in exosome-based cancer treatments.

Main Methods:

• Literature review of exosome function in solid tumors.
• Analysis of exosome cargo, including antigens, MHC molecules, and immune-modulatory factors.
• Examination of engineered exosome technologies for drug delivery and immune stimulation.

Main Results:

• Exosomes facilitate intercellular communication and immune modulation, impacting solid tumor progression.
• Engineered exosomes demonstrate enhanced drug bioavailability, tumor targeting, and immune stimulation.
• Exosomes are versatile platforms for cancer vaccines, drug delivery, and combinatorial therapies.

Conclusions:

• Exosomes hold significant potential for developing novel and effective solid cancer treatments.
• Advances in exosome engineering are crucial for personalized medicine approaches.
• Further research is needed to address clinical and technical challenges for exosome-based therapies.